Nektar Therapeutics to Host Virtual Investor & Analyst Event with Dermatology Experts on September 13th

SAN FRANCISCO, Sept. 6, 2023 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced that it will host a virtual investor and analyst event on Wednesday, September 13, 2023 at 11:00 a.m. EST / 8:00 a.m. PST to discuss the final Phase 1b data of rezpegaldesleukin (REZPEG) in…

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks